64 related articles for article (PubMed ID: 38712609)
1. Clinicopathologic and prognostic significance of regulatory T cells in patients with hepatocellular carcinoma: a meta-analysis.
Sun L; Xu G; Liao W; Yang H; Xu H; Du S; Zhao H; Lu X; Sang X; Mao Y
Oncotarget; 2017 Jun; 8(24):39658-39672. PubMed ID: 28487498
[TBL] [Abstract][Full Text] [Related]
2. Roles of Tregs in development of hepatocellular carcinoma: a meta-analysis.
Zhao HQ; Li WM; Lu ZQ; Yao YM
World J Gastroenterol; 2014 Jun; 20(24):7971-8. PubMed ID: 24976734
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in viral and autoimmune liver diseases: Role of CD4+ CD25+ Foxp3+ regulatory T cells in the immune microenvironment.
Granito A; Muratori L; Lalanne C; Quarneti C; Ferri S; Guidi M; Lenzi M; Muratori P
World J Gastroenterol; 2021 Jun; 27(22):2994-3009. PubMed ID: 34168403
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract][Full Text] [Related]
5. Regulatory T cells, especially ICOS
Tu JF; Ding YH; Ying XH; Wu FZ; Zhou XM; Zhang DK; Zou H; Ji JS
Sci Rep; 2016 Oct; 6():35056. PubMed ID: 27725696
[TBL] [Abstract][Full Text] [Related]
6. Intrahepatic interleukin-17+ T cells and FoxP3+ regulatory T cells cooperate to promote development and affect the prognosis of hepatocellular carcinoma.
Huang Y; Wang F; Wang Y; Zhu Z; Gao Y; Ma Z; Xu R; Du Z
J Gastroenterol Hepatol; 2014 Apr; 29(4):851-9. PubMed ID: 24303990
[TBL] [Abstract][Full Text] [Related]
7. Comparative analyses of regulatory T cell subsets in patients with hepatocellular carcinoma: a crucial role of CD25(-) FOXP3(-) T cells.
Kakita N; Kanto T; Itose I; Kuroda S; Inoue M; Matsubara T; Higashitani K; Miyazaki M; Sakakibara M; Hiramatsu N; Takehara T; Kasahara A; Hayashi N
Int J Cancer; 2012 Dec; 131(11):2573-83. PubMed ID: 22419479
[TBL] [Abstract][Full Text] [Related]
8. Clinical prognostic value of CD4+CD25+FOXP3+regulatory T cells in peripheral blood of Barcelona Clinic Liver Cancer (BCLC) stage B hepatocellular carcinoma patients.
Li F; Guo Z; Lizée G; Yu H; Wang H; Si T
Clin Chem Lab Med; 2014 Sep; 52(9):1357-65. PubMed ID: 24646790
[TBL] [Abstract][Full Text] [Related]
9. Increased intratumoral regulatory T cells are related to intratumoral macrophages and poor prognosis in hepatocellular carcinoma patients.
Zhou J; Ding T; Pan W; Zhu LY; Li L; Zheng L
Int J Cancer; 2009 Oct; 125(7):1640-8. PubMed ID: 19569243
[TBL] [Abstract][Full Text] [Related]
10. CXCL13 Positive Cells Localization Predict Response to Anti-PD-1/PD-L1 in Pulmonary Non-Small Cell Carcinoma.
Vahidian F; Lamaze FC; Bouffard C; Coulombe F; Gagné A; Blais F; Tonneau M; Orain M; Routy B; Manem VSK; Joubert P
Cancers (Basel); 2024 Feb; 16(4):. PubMed ID: 38398098
[No Abstract] [Full Text] [Related]
11. Toxicity-specific peripheral blood T and B cell dynamics in anti-PD-1 and combined immune checkpoint inhibition.
van Eijs MJM; Verheijden RJ; van der Wees SA; Nierkens S; van Lindert ASR; Suijkerbuijk KPM; van Wijk F;
Cancer Immunol Immunother; 2023 Dec; 72(12):4049-4064. PubMed ID: 37794264
[TBL] [Abstract][Full Text] [Related]
12. Prognostic values of tissue-resident CD8
Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
[TBL] [Abstract][Full Text] [Related]
13. Crosstalk between dendritic cells and regulatory T cells: Protective effect and therapeutic potential in multiple sclerosis.
Li R; Li H; Yang X; Hu H; Liu P; Liu H
Front Immunol; 2022; 13():970508. PubMed ID: 36177043
[TBL] [Abstract][Full Text] [Related]
14. The immune checkpoint B7x expands tumor-infiltrating Tregs and promotes resistance to anti-CTLA-4 therapy.
John P; Pulanco MC; Galbo PM; Wei Y; Ohaegbulam KC; Zheng D; Zang X
Nat Commun; 2022 May; 13(1):2506. PubMed ID: 35523809
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
